期刊文献+

老年冠心病患者PCI围术期出血状况与预后的关联性研究 被引量:1

下载PDF
导出
摘要 目的探讨经皮冠状动脉介入治疗的老年冠心病患者围术期出血状况与术后12个月疾病预后的关联性。方法选择行经皮冠状动脉介入治疗的老年冠心病患者224例,根据经皮冠状动脉介入治疗围术期是否出血分为未出血组183例与出血组41例。应用Cox回归模型分析PCI围术期内出血与手术后12个心肌梗死和死亡复合事件终点关系。结果 41例出血患者中,BARC≥2级比率为85.4%(35/41),BARC 5级占整个出血事件的比率最低为2.4%,BARC 2级占整个出血事件的比率则最高为68.3%;穿刺部位相关性出血率为63.4%。出血组患者住院期间内的心肌梗死率以及病死率均明显高于未出血组(P均<0.05);出血组患者PCI术后12个月的心血管不良事件率明显高于未出血组,其中因心源性死亡以及全因病死率明显高于未出血组(P<0.05)。以未出血组为参照进行Cox回归模型分析,出血BARC≥2级患者PCI治疗12个月后心肌梗死以及死亡复合终点的HR值是2.373[95%CI(1.199,4.670),P<0.05]。结论 75周岁及以上老年冠心病患者经皮冠状动脉介入治疗围术期内出血(BARC≥2级)是术后12个月心肌梗死以及死亡复合事件的独立性危险因素,降低PCI围术期内出血率是提高老年冠心病患者PCI术预后的重要手段。
出处 《现代中西医结合杂志》 CAS 2017年第28期3123-3126,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献3

二级参考文献74

  • 1冯国勤,杨进,王新宝,孟春,林灵丹,吴汉利.老年人血清胆红素水平与冠状动脉病变程度的关系[J].中国动脉硬化杂志,2007,15(4):311-312. 被引量:6
  • 2Doyle B J, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long- term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005[J]. JACC Cardiovasc Interv,2008,1 (2):202-209.
  • 3Applegate R J, Sacrinty MT, Kutcher MA, et al. Trends in vascular c omplica- tions after diagnostic cardiac :atheterization and percutaneous coronary interven- tion via the femoral artery, 1998 to 2007[J]]. JACC Cardiovasc lnterv,2008,1 (3) :317-326.
  • 4Ahmed B, Piper WD, Malenka D, et al. Significantly improved vascular com- p]ications among women undergoing percutaneous coronary intervention: a report from the Northetaa New England Percutaneous Coronary Intervention Registry [J]. Circ Cardiovasc lnterv,2009,2(5) :423-429.
  • 5Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology[J]. Eur Heart J,2011,32 (15) :1854-1864.
  • 6Dauerman HJ,, Rao SV, Resnic FS, et al. Bleeding avoidance strategies. Con- sensus and cgntroversy [ J ]. J Am Coil Cantio1,2011,58 ( 1 ) : 1 -10.
  • 7Subherwal S, Pete on ED, Dai D, et al. Temporal trends in arid factors associ- ated with bleeding complications among patients undergoing percutaneous coro- nary intervention: a report from the National Cardiovascular Data CathPCl Reg- istry[J]. J Am Coil Cardiol,2012,59(21 ) :l861-1969.
  • 8Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for ear- diovascular clinical trials: a consensus report from the Bleeding Academic Re- search Consortium[J]. Circulation,2011,123(23) :2736-2747.
  • 9Rao A K, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TI- MI) Trial--phase 1: hemorrhagic manifestations and changes in plasma fibrino- gen and the fibrinolytic system in paiients treated with recombinant tissue plas- minogen activator and streptokinase[ J ]. J Am Coil Cardiol, 1988,11 ( 1 ) : 1-11.
  • 10The Gusto Investigators. An international randomized trial comparing four throm- bolytic strategies for acute myocardial infarction. The GUSTO investigators[ J ]. N Engl J Med,1993,329(10) :673-682.

共引文献14

同被引文献8

引证文献1

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部